Abbott India Limited vs Mphasis Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Mphasis Limited (Information technology services and consulting) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Mphasis Limited leads on Revenue (approx.) and Net profit (approx.).
Mphasis Limited leads on Revenue (approx.) and Net profit (approx.).
Head-to-head highlights
| Metric | Abbott India Limited | Mphasis Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Approximately ₹13,000–14,000 crore, unverified | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Approximately ₹1,500–1,700 crore, unverified | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Mphasis Limited
Information technology services and consulting · India
Mphasis Limited is an India-based IT services company providing application development, cloud, infrastructure, digital transformation, data, AI, and business process services. The company serves global enterprises, with a strong historical focus on banking, financial services, insurance, logistics, and technology clients.
Verified financials
No source-verified financials available.
Strengths
- Strong presence in banking, financial services, and insurance technology services
- Global delivery model with significant India-based delivery capabilities
- Backing and strategic influence from Blackstone as a major shareholder
- Established capabilities in cloud, digital, data, and application services
Weaknesses
- High exposure to cyclical enterprise IT spending, especially in financial services
- Smaller scale than the largest Indian and global IT services firms
- Dependence on large clients and long sales cycles for major transformation deals
- Margin pressure from wage inflation and competitive pricing
Opportunities
- Growing demand for cloud modernization and AI-led enterprise transformation
- Expansion into higher-value consulting and digital engineering services
- Cross-selling to existing financial services and insurance clients
- Use of automation and generative AI to improve delivery productivity
Threats
- Slowdowns in discretionary technology spending by enterprise clients
- Intense competition from larger IT services firms and specialist digital agencies
- Currency volatility affecting reported revenue and margins
- Rapid technology shifts requiring continuous investment in skills and platforms
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Mphasis Limited: which company leads overall?
Mphasis Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Embedded Finance & Banking-as-a-Service (BaaS) Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
India Protein Industry Outlook — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Mphasis Limited's verified data. Modeled estimates — not investment advice.
Not enough data yet to generate insights.